Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05280093 · ClinicalTrials.gov registry record · NA
HEAL-IST IDE Trial
A NA study of Inappropriate Sinus Tachycardia, sponsored by AtriCure.
- Active
- Registry status
- NA
- Development phase
- 142
- Enrollment target
- 20
- Study locations
NCT05280093 is a NA study of Inappropriate Sinus Tachycardia that is active but no longer recruiting, run by AtriCure. The registered enrollment target is 142 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT05280093, a NA study of Inappropriate Sinus Tachycardia, is active but no longer recruiting, sponsored by AtriCure.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
- 20
- Study locations
Study Summary
Inappropriate Sinus Tachycardia (IST) is a prevalent and debilitating condition in otherwise healthy younger patients, resulting in significant loss of quality of life, lacking effective treatment options or systematic clinical evidence to support a therapy. The primary objective of this clinical trial is to evaluate the safety and effectiveness of a hybrid sinus node sparing ablation procedure for the treatment of symptomatic drug refractory or drug intolerant IST.
Conditions Studied
Interventions
- DEVICE AtriCure ISOLATOR Synergy Surgical Ablation System
Study Locations (20)
Florida
- University of Florida - Gainesville
- Baptist Health - Miami
- Sarasota Memorial Hospital - Sarasota
- St. Joseph's Hospital / Baycare Health System - Tampa
California
- Loma Linda University Health - Loma Linda
- Sequoia Hospital - Redwood City
- Stanford University - Redwood City
Ohio
- TriHealth, Inc. - Cincinnati
- The Christ Hospital - Cincinnati
Arkansas
- St. Bernard - Jonesboro
Connecticut
- Saint Vincent's Medical Center - Bridgeport
District of Columbia
- Medstar Washington Hospital Center - Washington D.C.
Georgia
- Memorial Health University Medical Center - Savannah
Idaho
- Saint Alphonsus Regional Medical Center - Boise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2022-05-31 |
| Est. Completion | 2028-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05280093
The ClinicalTrials.gov registry entry for NCT05280093 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Inappropriate Sinus Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which AtriCure ISOLATOR Synergy Surgical Ablation System is the first listed.
NCT05280093 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Florida, California, Ohio.
Frequently Asked Questions
What is clinical trial NCT05280093 about?
NCT05280093 is a clinical study titled "HEAL-IST IDE Trial". Inappropriate Sinus Tachycardia (IST) is a prevalent and debilitating condition in otherwise healthy younger patients, resulting in significant loss of quality of life, lacking effective treatment options or systematic clinical evidence to support a therapy. The primary objective of this clinical tr...
What is the current status of trial NCT05280093?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 142 participants. The study started on 2022-05-31. Estimated completion is 2028-02.
What conditions does trial NCT05280093 study?
This clinical trial studies the following conditions: Inappropriate Sinus Tachycardia.
What interventions are being tested in trial NCT05280093?
The interventions under investigation include: AtriCure ISOLATOR Synergy Surgical Ablation System (DEVICE).
Who is sponsoring clinical trial NCT05280093?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05280093 being conducted?
This trial has 20 study locations across Arkansas, California, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inappropriate Sinus Tachycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.